<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-04QM1G3D</identifier><date>2012</date><creator>Kelc, Robi</creator><creator>Topolovec, Janja</creator><relation>documents/doc/0/URN_NBN_SI_doc-04QM1G3D_001.pdf</relation><relation>documents/doc/0/URN_NBN_SI_doc-04QM1G3D_001.txt</relation><format format_type="issue">2</format><format format_type="volume">51</format><format format_type="type">article</format><format format_type="extent">str. 145-157</format><identifier identifier_type="ISSN">0025-8121</identifier><identifier identifier_type="COBISSID">4351551</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-04QM1G3D</identifier><language>slv</language><publisher>Medicinski razgledi</publisher><source>Medicinski razgledi</source><rights>InC</rights><subject language_type_id="eng">Antibodies, Monoclonal</subject><subject language_type_id="eng">biological drugs</subject><subject language_type_id="slv">biološka zdravila</subject><subject language_type_id="eng">inflammatory mediators</subject><subject language_type_id="slv">Monoklonska protitelesa</subject><subject language_type_id="eng">Neoplasms</subject><subject language_type_id="slv">Novotvorbe</subject><subject language_type_id="eng">signal molecules</subject><subject language_type_id="slv">signalne molekule</subject><subject language_type_id="slv">tarčni proteini</subject><subject language_type_id="eng">target proteins</subject><subject language_type_id="eng">Therapy</subject><subject language_type_id="eng">tumor</subject><subject language_type_id="slv">vnetni mediatorji</subject><subject language_type_id="slv">Zdravljenje</subject><title>Trendi uporabe in razvoja bioloških zdravil za zdravljenje malignih obolenj</title><title>Trends of usage and development of biological drugs for treatment of malignancies</title></Record>